Menu

Vegashares Trillions ETF TRIL

Full chart Compare
Set alert

Price alert · TRIL

All alert types
22.14 USD +0.36 (+1.65%)

At closeNov 6, 2026, 4:04 PM EST

22.14 0.00 0.00%

After hours · Nov 6, 4:04 PM ET

22.14 Day range 22.14
21.79 52-week range 26.03
YTD
-11.81%
1 year
-11.81%

Discussion (29)

Sign in to join the discussion

BAFERD21 TRIL 5 years ago #1

Yeah, so shorts and spammers seem to be running free and loose here today...

3000 shares is not executive dumping. Sometimes people take a little profit along the way - especially when they have more options...
I’ve sold many times more than that and still have a giant pile of shares (0.37 avg...love this stock!)

BAFERD21 TRIL 5 years ago #3

What’s the source of the Merck rumor?

BAFERD21 TRIL 5 years ago #4

It’s interesting that out of all the combo therapy studies announced, they are continuing with one mono therapy study (primary t-cell lymphoma) because “there are no good agents available” to treat in combo...

Not just bullish as an investor - this is an exciting time to watch cancer therapies evolve!

BAFERD21 TRIL 5 years ago #5

Predictions:
April 28 - 622 data readout, multiple combo therapy stage 3 trials announced.
Price goes to 20-50$ a share.

May 1 - buyout offer.

May 2 - I pay off my mortgage.

BAFERD21 TRIL 5 years ago #6

PT for conference:

I think announcement of 622 results alone is going to be a major catalyst, but it was surmised/intimated that combo studies would be announced/discussed that day - expanded solid tumor application, etc. I believe that solidly puts tril at the stage where 47inc was when they took off.
As such, I’m very bullish that this carries us up to 20-40$ range, which will be a buyout zone.

Lee TRIL 5 years ago #8

Add more on $12.18. I believe science data :)

GrandMaster TRIL 6 years ago #10

Now turning positive, yes baby thats the way I like it.